Investor profile for Prosper HealthTech Accelerator: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

Prosper HealthTech Accelerator stages, portfolio and investment profile

gener8tor-powered 12-week in-person healthtech accelerator in Birmingham. Published program terms include $50k for 5% common stock, with optional additional capital that can bring total investment up to roughly $90k; cohorts relocate to Birmingham for the program.

Keep track of Prosper HealthTech Accelerator

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$250K–$3M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: Not recorded View methodology

Investment stages

Leads: Pre-Seed, Seed

Participates: Pre-Seed, Seed

Sector focus

Healthtech

Geography

Birmingham, AL

Founded 2021

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

2

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Dialytix

Accelerator · $60K · April 2024

Rounds they lead

Pre-Seed Seed

Rounds they invest

Pre-Seed Seed

Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

Portfolio companies we track

Startups in our directory that list Prosper HealthTech Accelerator as an investor (2 total).

Related investment articles

FAQs about Prosper HealthTech Accelerator

Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.

Per our directory, Prosper leads and invests at pre-seed and seed through its accelerator check. It is a 12-week program investment, not a traditional multi-stage venture fund writing Series A leads.
Published terms cite $50k for 5% common stock, with optional additional capital that can bring total program investment to roughly $90k. Founders should confirm current terms on the gener8tor Prosper HealthTech page before applying, as accelerator structures can change by cohort.
The program is in-person in Birmingham, AL. Cohort companies relocate to Birmingham for the 12-week accelerator; remote-only participation is not how the public program is described.
Our directory tags healthtech. Prosper is a healthtech-focused accelerator powered by gener8tor, aimed at early-stage companies building products for care delivery, health systems, and related digital health markets.
Prosper leads the standard accelerator investment into accepted cohort companies. Larger follow-on rounds after Demo Day typically come from other seed investors and angels; Prosper is program-first capital.
Prosper HealthTech is powered by gener8tor and runs as an investment accelerator with a Birmingham in-person residency. Application and program details live on gener8tor's Prosper HealthTech accelerator page.
Apply through gener8tor.com when the Prosper HealthTech application window is open. Be ready to commit to the Birmingham residency and to published equity terms; warm intros help but the formal application is the main path.
We do not yet have a dedicated Prosper HealthTech article. For related context, see our healthtech industry hub and Birmingham early-stage investor coverage as those pages expand.

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.